As radiation therapy develops more sophisticated targeting, researchers are turning to new imaging methods to direct it. Fused scintigraphy and CT images and daily ultrasound scanning both show promise as tools to concentrate intensity-modulated radiation therapy (IMRT) and spare surrounding healthy tissue.
As radiation therapy develops more sophisticated targeting, researchers are turning to new imaging methods to direct it. Fused scintigraphy and CT images and daily ultrasound scanning both show promise as tools to concentrate intensity-modulated radiation therapy (IMRT) and spare surrounding healthy tissue.
Researchers at the Mayo Clinic in Scottsdale, AZ, use ProstaScint scans fused with axial CT images of the pelvic region to target hot spots within the prostate. Because the imaging agent is taken up by bone, blood vessels, the bladder, and other anatomic landmarks, coregistration can be closely approximated, according to lead author Dr. Steven Schild.
In 43 patients, Schild and colleagues delivered treatment doses averaging 75.6 Gy over 42 fractions. They set strict limits for how much peripheral radiation exposure would be acceptable in the bladder and rectum.
Among 38 patients followed for six months, only one patient (2%), showed a grade 3 gastrointestinal toxicity. Another 48% showed grade 2 toxicity that could be treated with Imodium. About half had genitourinary symptoms of similar grade. Prostate-specific antigen levels dropped from an average of 6.9 before treatment to 1.9 after.
Researchers in Dijon, France, are using daily ultrasound studies to account for minor shifts in the prostate that could skew IMRT targeting. A software protocol that overlays 3D ultrasound on a simulation-planning CT has been able to track movement of 4 to 6 mm on different axes. The five-minute scan has been incorporated into routine practice since the initial study of 37 patients.
Both techniques underscore an evolution in therapy and targeting, Schild said.
"As we move to more image-guided therapy and to PET and PET/CT for planning, this is an area ripe for future investigation," he said.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
What New Research Reveals About ChatGPT and Ultrasound Detection of Thyroid Nodules
March 13th 2024In a comparison of image-to-text large language models (LLMs), ChatGPT 4.0 offered a 95 percent sensitivity rate and an 83 percent AUC that were comparable to that of two senior radiologists and one junior radiologist interacting with LLM to differentiate between malignant and benign thyroid nodules on ultrasound.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.